DiscoverJAMA Ophthalmology Author InterviewsContinuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab

Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab

Update: 2025-03-06
Share

Description

Interview with Arshad M. Khanani, MD, author of Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial. Hosted by Neil Bressler, MD.

Related Content:

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab

Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab